Michael F. DeMane - 07 Jun 2023 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael F. DeMane
Issuer symbol
N/A
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 16:36:03 UTC
Previous filing
30 May 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Gift $0 -80,000 -74% $0.000000 27,772 07 Jun 2023 Direct F1
holding NVRO Common Stock 164,344 07 Jun 2023 See footnote F2
holding NVRO Common Stock 122,541 07 Jun 2023 See footnote F3, F6
holding NVRO Common Stock 131,225 07 Jun 2023 See footnote F4, F6
holding NVRO Common Stock 18,266 07 Jun 2023 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 6,754 restricted stock units.
F2 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017 (the "SLAT Trust").
F4 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust").
F5 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.
F6 Reflects the transfer of 40,000 directly held shares to each of the SLAT Trust and the 2011 Trust on June 7, 2023.